JTI completed the acquisition of U.S. tobacco company Vector Group last year, which pushed its share of the super value ...
UNC Charlotte officially achieved Research 1, or R1, status this week, after doubling its research spending over the last ...
Finally, organisations should look to AI security leaders to help mitigate immediate cyber-related risks. Zero trust is an ...
HotCars on MSN3d
This Was The World's Most Powerful Car In The '80sWhat if a car could be built with the same level of precision as a fighter jet? What if it had more power than anything from ...
In the past, multiple ECUs were implemented as part of a vehicle’s security strategy, but carmakers increasingly are relying ...
The transmission on the 249-mile-per-hour Koenigsegg Gemera alone is a marvel of engineering with six clutches and nine gears ...
With so many places to buy a used car, finding the best one can seem overwhelming. Knowing the pros and cons of each can help. Many, or all, of the products featured on this page are from our ...
Claims are easy. But proving it in real life is a different thing. Just ask some of the supercars that made the headlines in ...
Citizen Sleeper 2 understands that you don't get to choose how your body grows. You can decide on some things if you're one ...
The changes will extend the company's cash runway, enabling it to advance a tri-specific CAR T-cell candidate and its allogeneic cell therapy platform.
CHICAGO, January 29, 2025--(BUSINESS WIRE)--VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy, UC101, received ...
VectorBuilder' s partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy, UC101, received Investigational New Drug (IND) approval from the U.S ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback